ASCCT 9th Annual Meeting: Preliminary program available
Tuesday October 20, 2020 12:00PM through Friday October 23, 2020 01:00PM
Given the continuing uncertainties related to travel and large gatherings, the organizing committee and board of directors have decided to proceed with a virtual ASCCT meeting. The meeting will still feature plenary speakers, panel discussions, oral and poster presentations drawn from submitted abstracts, and opportunities for early-career scientists through a mentoring session and poster awards.
The 9th Annual ASCCT meeting will be held October 20-22nd, culminating with an add-on training on the EPA Chemistry Dashboard and related tools October 23rd. No registration fee will be charged. Participation will be via online platforms including GoToWebinar, WebEx, or Zoom. We will choose the platform that maximizes participation and supports a robust and interesting meeting, and may add other online tools to encourage engagement.
Registration will be available in early fall.
Abstract submission closed August 7th. There may be a few poster slots available; please email email@example.com for more information.
- Abstract body limit is 250 words.
- Submitters can choose their presentation format as “Poster”, “Oral”, or “Either”. The abstracts will be reviewed for quality, relevance, novelty, and potential to advance the fields of in vitro and in silico toxicology. The program committee will select from those indicating “Oral” or “Either” for oral presentations. Those choosing “Poster” and remaining “Eithers” will be offered a poster presentation slot.
- Poster presentation format will depend on how many abstracts are submitted and chosen. Presenters will likely have an opportunity to give a 3-minute flash presentation, followed by discussion in small groups via an online platform with audio and video. Poster presenters may be asked to create a traditional PDF poster for attendees to view.
The organizing committee is committed to putting on a stimulating and engaging meeting. We are exploring platforms that will allow ASCCT members and guests the opportunity to share their science and network with colleagues despite remaining at home.
Perhaps this will be an opportunity to increase meeting attendance! We hope you will join us. Most of the meeting program is built from submitted abstracts, so please submit your abstracts today and help us shape the future of in vitro and in silico toxicology.
This program is subject to change depending on topic and number of abstracts submitted and available of speakers.
The conference theme will address the US EPA goal to eliminate reliance on mammalian tests to make regulatory decisions by 2035, and the various considerations—science and policy—related to meeting this goal.
Plenary speakers include:
- Tara Barton-McLaren, Health Canada
- Richard Keigwin, US EPA (invited)
- Sue Marty, Dow Chemical
- Adrian Roth, Roche
Presentations and discussions will consider:
- Solutions and research needed for longer-term and complex endpoint replacement
- Fit for purpose validation frameworks and case studies
- Needs of the regulated and regulator community
- Benchmarking NAMs without in vivo tests
- Public communication
- Overcoming barriers related to comfort, training, and experience
- Effects on, and contributions from, pharmaceutical and other sectors
Please also note that we are coordinating with EPA depending on their scheduling of a NAMs workshop this same week, and we’ll make sure you don’t have to choose one event or the other. Your participation is needed to accomplish a stimulating and engaging meeting!